1961
DOI: 10.1056/nejm196104062641404
|View full text |Cite
|
Sign up to set email alerts
|

Hypophyseal-Stalk Section in the Treatment of Advancing Diabetic Retinopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
6
1
1

Year Published

1962
1962
2002
2002

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 32 publications
(9 citation statements)
references
References 9 publications
1
6
1
1
Order By: Relevance
“…Three studies of untreated proliferative retinopathy put the progression to blindness at 27-50% [23,29,35], whereas in the present study group the percentage of patients blind in both eyes remained at 12% from 3 to 15 years. The difference in visual acuity between the right and left eyes has been previously noted [36], and it has been postulated that this is due to differences in blood supply between the two eyes. In the analysis of this data the role of photocoagulation is a complicating factor, as it played an increasing part in treatment as the benefits of the xenon, and later the argon, photocoagulators became obvious.…”
Section: Discussionmentioning
confidence: 79%
“…Three studies of untreated proliferative retinopathy put the progression to blindness at 27-50% [23,29,35], whereas in the present study group the percentage of patients blind in both eyes remained at 12% from 3 to 15 years. The difference in visual acuity between the right and left eyes has been previously noted [36], and it has been postulated that this is due to differences in blood supply between the two eyes. In the analysis of this data the role of photocoagulation is a complicating factor, as it played an increasing part in treatment as the benefits of the xenon, and later the argon, photocoagulators became obvious.…”
Section: Discussionmentioning
confidence: 79%
“…Apesar da importância dada ao efeito de secção da haste, ela, por si só, não pode explicar: 1. ausên-cia de correlação entre hiperprolactinemia e tamanho tumoral em pseudoprolactinomas 6 ; 2. níveis variáveis de hiperprolactinemia, em secção terapêu-tica ou experimental da haste feitas no passado 16,17 ; 3. a falta de concomitância entre hiperprolactinemia e hipopituitarismo, em massas expansivas selares, diferente do que ocorre quando a haste é seccionada experimentalmente 6 ; 4. os tumores de tamanho similar com diferentes expressões, clínica e laboratorial, encontrados no dia a dia; 5. sela vazia associada com hiperprolactinemia e haste visivelmente estirada, frequentemente sem hipopituitarismo 6 ; 6. a presença de adenoma gigante com discreto distúrbio hormonal 14 ; 7. a presença de macroincidentaloma 1,29 , assim como a apoplexia hipofisária em macroadenomas sem história prévia de endocrinopatia 1 ; 8. a presença de hiperprolactinemia em pacientes com microadenomas TNF (32% dos TNF) 18 ; 9. a prevalência maior de hipopituitarismo grave, pré e pós-operatórios, em macroadenomas-TNF do que macroadenomas secretores de GH 5 Em estudos experimentais e clínicos, os motivos supostos para explicar essa variação dos níveis de prolactina entre TNF e lesões expansivas não hipofisárias foram: 1. rotas alternativas da liberação de dopamina para a adeno-hipófise, além do sistema portal curto através da neuro-hipófise; 2. secção incompleta ou somente distorção parcial da haste pelo tumor, preservaria o sistema de liberação de dopa- mina da neuro-hipófise; 3. liberação de prolactina dos lactotrofos lesados; 4. aumento da pressão intraselar (PIS) 6,19,20. Em 1987, Lees et al 20 e, em 2000, Arafah et al 9 demostraram que a pressão intra-selar média foi mais alta em pacientes com hiperprolactinemia comparados com aqueles de prolactina normal. Não se sabe qual o valor normal da pressão intra-selar, mas é provavel que não exceda a pressão intracraniana 6,9 .…”
Section: Métodounclassified
“…Reports have been published of 223 patients with diabetic retinopathy who have undergone pituitary ablation by one of several techniques (Luft et al, 1955 ;Kinsell, 1957;Javid et al, 1958 ;Vannas et al, 1959;Ray, 1960;Field et al, 1961Field et al, , 1962Bryan, 1962;Gordon and Javid, 1962;Pearson et al, 1962;Joplin et al, 1962;Sjdgren, 1962;Lundbaek et al, 1962;Ainslie et al, 1962;Lawrence et al, 1963). Records of results have varied in form and adequacy, but they suggest that 98 (48%) patients showed a reduction in the tendency to retinal haemorrhage.…”
Section: Bsrash Medical Journalmentioning
confidence: 99%